| Earum Pharmaceuticals Ltd |
|
Registered Office:
G1 Ground Floor VR Complex,Nr Sanathal Cross Rd SP RingRd
,
Ahmedabad
-
382210
,
Gujarat
, India.
Phone :
91-79-48402525 Fax:
Email : cs@earumpharma.com
Website : www.earumpharma.com
|
Initial Public Offer of 18,48,000 equity shares of face value of  10 each (the "equity shares") of Earum Pharmaceuticals Limited ("the company" or "epl" or "the issuer") at an issue price of 36 per equity share for cash, aggregating up to 6.65 Crores ("public issue") out of which 96,000 equity shares of face value of 10 each, at an issue price of 36 per equity share for cash, aggregating 0.35 Crores will be reserved for subscription by the market maker to the issue (the "market maker reservation portion"). the public issue less market maker reservation portion i.e. issue of 17,52,000 equity shares of face value of 10 each, at an issue price of 36 per equity share for cash, aggregating upto 6.31 Crores is here in after referred to as the "net issue". the public issue and net issue will constitute 29.96% and 28.41 % respectively of the post issue paid-up equity share capital of the company.
The face value of the equity share is 10 each.
Fixed Price issue at 36 per share and is 3.6 times of the face value.
|
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 21-Jun-19 |
26-Jun-19 |
Rs36.00-0.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :3000 Further Multiples of :3000 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
6.65 |
|
| Project Financed through Current Offer |
6.65 |
|
| Post Issue Equity Share Capital |
6.17 |
|
| Issue Price |
Rs36.00 |
|
|